Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
By doing this study, researchers will examine the safety and tolerability of R-pramipexole in
participants with Alzheimer's disease. This study will also examine the body and brain's
response to the study drug by measuring the amount of injury to the cells (oxidative stress)
in the blood and spinal fluid and brain imaging before and after treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborators:
Alzheimer's Drug Discovery Foundation Alzheimer’s Drug Discovery Foundation University of Kansas University of Kansas Medical Center